Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Vaccine Induced Immune-Inflammatory Response and Cardiovascular Risk
CEDARS-SINAI MEDICAL CENTER, NATIONAL INSTITUTES OF HEALTH (NIH)
4/1/21 → 3/31/25
Project: Research project
-
INfluenza Vaccine to Effectively Stop Cardio Thoracic Ev
BRIGHAM AND WOMEN'S HOSPITAL, NATIONAL INSTITUTES OF HEALTH (NIH)
9/6/17 → 1/31/22
Project: Research project
-
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)
Solomon, S. & Vardeny, O.
National Heart, Lung, and Blood Institute
2/15/16 → 1/31/21
Project: Research project
-
Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial
Peikert, A., Bart, B. A., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Kosiborod, M. N., Desai, A. S., Jhund, P. S., Lam, C. S. P., Inzucchi, S. E., Martinez, F. A., de Boer, R. A., Hernandez, A. F., Shah, S. J., Petersson, M., Langkilde, A. M., McMurray, J. J. V., Solomon, S. D. & Vardeny, O., Apr 2024, In: JACC: Heart Failure. 12, 4, p. 631-644 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials
Bhatt, A. S., Vaduganathan, M., Claggett, B. L., Kulac, I. J., Anand, I. S., Desai, A. S., Fang, J. C., Hernandez, A. F., Jhund, P. S., Kosiborod, M. N., Sabatine, M. S., Shah, S. J., Vardeny, O., McMurray, J. J. V., Solomon, S. D. & Gaziano, T. A., Mar 5 2024, In: Journal of the American Heart Association. 13, 5, e032279.Research output: Contribution to journal › Article › peer-review
-
Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction A Post Hoc Analysis of the DELIVER Trial
Vardeny, O., Desai, A. S., Jhund, P. S., Fang, J. C., Claggett, B., de Boer, R. A., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F. A., Shah, S. J., Mc Causland, F. R., Petrie, M. C., Vaduganathan, M., McMurray, J. J. V. & Solomon, S. D., 2024, (Accepted/In press) In: JAMA cardiology.Research output: Contribution to journal › Article › peer-review
Open Access -
Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial
Mc Causland, F. R., Claggett, B. L., Vaduganathan, M., Desai, A., Jhund, P., Vardeny, O., Fang, J. C., de Boer, R. A., Docherty, K. F., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., Kerr Saraiva, J. F., McGrath, M. M., Shah, S. J., Verma, S., Langkilde, A. M., Petersson, M., & 2 others , Feb 14 2024, In: JAMA cardiology. 9, 2, p. 144-152 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial
Bauersachs, J., Solomon, S. D., Anker, S. D., Antorrena-Miranda, I., Batkai, S., Viereck, J., Rump, S., Filippatos, G., Granzer, U., Ponikowski, P., de Boer, R. A., Vardeny, O., Hauke, W. & Thum, T., 2024, (Accepted/In press) In: European Journal of Heart Failure.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations
Press/Media
-
Coronavirus Threatens Americans With Underlying Conditions
Orly Vardeny & Michael T Osterholm
3/12/20
1 item of Media coverage
Press/Media: Expert Comment